Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > CORONAVIRUS STOCKS ONLY PLAY IN TOWN
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by 007daveon Mar 12, 2020 8:21pm
75 Views
Post# 30801974

RE:RE:CORONAVIRUS STOCKS ONLY PLAY IN TOWN

RE:RE:CORONAVIRUS STOCKS ONLY PLAY IN TOWNAgree with Mr Weed. Key word there is research. Takes years of research and trial and error to come up with new medical technologies or vaccines for that matter. Alot of these fly by night pumpers just appeared weeks ago and will be gone in weeks. LXG has already done all the research and trials for the past few years. Caronavirus was never on their radar till now because human testing was never part of their initial platform, because of slow FDA approval. Veterinary and food safety was. Unfortunately we have no idea on the progress for FDA fast track, would be nice to know what measures the company is making as they say for FDA approval.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities